logo True scholar network
Back to Top
Visit Website Disclaimer

Brain, Behavior, and Immunity (BBI)

Publisher :

Elsevier

Scopus Profile
Peer reviewed only
Scopus Profile
Open Access
  • Neuroscience
  • Behavioral Neuroscience
  • Immunology

    • +2

e-ISSN :

1090-2139

Issue Frequency :

Bi-Monthly

Impact Factor :

15.1

p-ISSN :

0889-1591

Est. Year :

1987

Mobile :

8006542452

Country :

United States

Language :

English

APC :

YES

Impact Factor Assignee :

Google Scholar

Email :

directorders@elsevier.com

Journal Descriptions

Brain, Behavior, and Immunity, founded in 1987, is the official journal of the Psychoneuroimmunology Research Society (PNIRS). This innovative journal publishes peer-reviewed basic, experimental, and clinical studies dealing with behavioral, neural, endocrine, and immune system interactions in humans and animals. It is an international, interdisciplinary journal devoted to original research in neuroscience, immunology, integrative physiology, behavioral biology, psychiatry, psychology, and clinical medicine and is inclusive of research at the molecular, cellular, social, and whole organism level. The journal features online submission and review. Manuscripts are typically peer-reviewed and returned to authors within 30 days of submission, leading to timely publication of experimental results. There are no submission fees or page charges for Brain, Behavior, and Immunity, which is published eight times a year.


Brain, Behavior, and Immunity (BBI) is :

International, Peer-Reviewed, Open Access, Refereed, Neuroscience, Behavioral Neuroscience, Immunology, Microbiology, Endocrine , Online or Print, Bi-Monthly Journal

UGC Approved, ISSN Approved: P-ISSN - 0889-1591, E-ISSN - 1090-2139, Established in - 1987, Impact Factor - 15.1

Not Provide Crossref DOI

Indexed in Scopus

Not indexed in WoS, DOAJ, PubMed, UGC CARE

Indexing

Scopus Profile
Scopus
Scopus Profile
Science Direct
Scopus Profile
SJR

+4 More

Publications of BBI

Research Article
  • dott image Eva Periche-Tomas
  • dott image January, 2025

Acute effects of interferon-alpha on cellular anabolic and catabolic processes are associated with the development of fatigue during Interferon-alpha-...

Introduction Interferon-alpha (IFN-α) is a key mediator of antiviral immune responses used to treat Hepatitis-C virus (HCV) infection. Though clinically effective, IFN-α frequently induce...

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile